...
首页> 外文期刊>Bioorganic and Medicinal Chemistry Letters >N,N-Dialkylated 4-(4-arylsulfonylpiperazine-1-carbonyl)-benzamidines and 4-((4-arylsulfonyl)-2-oxo-piperazin-1-ylmethyl)-benzamidines as potent factor Xa inhibitors.
【24h】

N,N-Dialkylated 4-(4-arylsulfonylpiperazine-1-carbonyl)-benzamidines and 4-((4-arylsulfonyl)-2-oxo-piperazin-1-ylmethyl)-benzamidines as potent factor Xa inhibitors.

机译:N,N-二烷基化的4-(4-芳基磺酰基哌嗪-1-羰基)-苯甲m和4-((4-芳基磺酰基)-2-氧代哌嗪-1-基甲基)-苯甲m为有效的Xa因子抑制剂。

获取原文
获取原文并翻译 | 示例

摘要

A class of N,N-dialkylated 4-(4-arylsulfonylpiperazine-1-carbonyl)-benzamidines and 4-((4-arylsulfonyl)-2-oxo-piperazin-1-ylmethyl)-benzamidines has been discovered as potent factor Xa inhibitors with desirable in vitro and in vivo anticoagulant activity, but with low oral bioavailability. The 5-chloroindole and 6-chlorobenzo[b]thiophene groups are optimal as the factor Xa S1 binding elements. The strategy of incorporating a side chain on the piperazine nucleus to enhance binding affinity has been examined.
机译:已经发现一类N,N-二烷基化的4-(4-芳基磺酰基哌嗪-1-羰基)-苯甲m和4-((4-芳基磺酰基)-2-氧代哌嗪-1-基甲基)-苯甲m是有效的因子Xa。抑制剂具有理想的体外和体内抗凝活性,但口服生物利用度低。 5-氯吲哚和6-氯苯并[b]噻吩基团是最佳的因子Xa S1结合元素。已经研究了在哌嗪核上掺入侧链以增强结合亲和力的策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号